United States - English - NLM (National Library of Medicine)

fresenius kabi usa, llc - floxuridine (unii: 039lu44i5m) (floxuridine - unii:039lu44i5m) - floxuridine 500 mg in 5 ml - floxuridine for injection, usp is effective in the palliative management of gastrointestinal adenocarcinoma metastatic to the liver, when given by continuous regional intra-arterial infusion in carefully selected patients who are considered incurable by surgery or other means.  patients with known disease extending beyond an area capable of infusion via a single artery should, except in unusual circumstances, be considered for systemic therapy with other chemotherapeutic agents. floxuridine therapy is contraindicated for patients in a poor nutritional state, those with depressed bone marrow function or those with potentially serious infections.

United States - English - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - floxuridine (unii: 039lu44i5m) (floxuridine - unii:039lu44i5m) - floxuridine 100 mg in 1 ml - floxuridine for injection, usp is effective in the palliative management of gastrointestinal adenocarcinoma metastatic to the liver, when given by continuous regional intra-arterial infusion in carefully selected patients who are considered incurable by surgery or other means. patients with known disease extending beyond an area capable of infusion via a single artery should, except in unusual circumstances, be considered for systemic therapy with other chemotherapeutic agents. floxuridine therapy is contraindicated for patients in a poor nutritional state, those with depressed bone marrow function or those with potentially serious infections.

United States - English - NLM (National Library of Medicine)

cerona therapeutics, inc. - floxuridine (unii: 039lu44i5m) (floxuridine - unii:039lu44i5m) - floxuridine for injection, usp is effective in the palliative management of gastrointestinal adenocarcinoma metastatic to the liver, when given by continuous regional intra-arterial infusion in carefully selected patients who are considered incurable by surgery or other means. patients with known disease extending beyond an area capable of infusion via a single artery should, except in unusual circumstances, be considered for systemic therapy with other chemotherapeutic agents. floxuridine therapy is contraindicated for patients in a poor nutritional state, those with depressed bone marrow function or those with potentially serious infections.

Canada - English - Health Canada

novartis pharmaceuticals canada inc - zoledronic acid (zoledronic acid monohydrate) - powder for solution - 4mg - zoledronic acid (zoledronic acid monohydrate) 4mg - bone resorption inhibitors

Canada - English - Health Canada

novartis pharmaceuticals canada inc - zoledronic acid (zoledronic acid monohydrate) - solution - 4mg - zoledronic acid (zoledronic acid monohydrate) 4mg - bone resorption inhibitors

Canada - English - Health Canada

sandoz canada incorporated - zoledronic acid (zoledronic acid monohydrate) - solution - 4mg - zoledronic acid (zoledronic acid monohydrate) 4mg - bone resorption inhibitors

Canada - English - Health Canada

pharmascience inc - zoledronic acid (zoledronic acid monohydrate) - solution - 4mg - zoledronic acid (zoledronic acid monohydrate) 4mg - bone resorption inhibitors

Canada - English - Health Canada

teva canada limited - zoledronic acid (zoledronic acid monohydrate) - solution - 4mg - zoledronic acid (zoledronic acid monohydrate) 4mg - bone resorption inhibitors